Furthermore, GLP-1R agonists have cardioprotective effects, including reducing hospitalization rates for HF, as recently discussed in detail elsewhere.151 GLP-1R agonists increase insulin secretion, reduce hunger, and delay gastric emptying. The gene discussed is INS; the disease is hydrops fetalis.